Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma.

Tete SM, Bijl M, Sahota SS, Bos NA.

Front Immunol. 2014 Jun 3;5:257. doi: 10.3389/fimmu.2014.00257. eCollection 2014. Review.

PMID:
24917865
[PubMed]
Free PMC Article
2.

Discovering the meaning of monoclonal gammopathy of undetermined significance: current knowledge, future challenges.

Palladino C, Bruno B, Boccadoro M.

Transl Med UniSa. 2014 Feb 4;8:12-8. eCollection 2014 Jan.

PMID:
24778994
[PubMed]
Free PMC Article
3.

The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.

van de Donk NW, Palumbo A, Johnsen HE, Engelhardt M, Gay F, Gregersen H, Hajek R, Kleber M, Ludwig H, Morgan G, Musto P, Plesner T, Sezer O, Terpos E, Waage A, Zweegman S, Einsele H, Sonneveld P, Lokhorst HM; European Myeloma Network.

Haematologica. 2014 Jun;99(6):984-96. doi: 10.3324/haematol.2013.100552. Epub 2014 Mar 21.

PMID:
24658815
[PubMed - in process]
Free PMC Article
4.

Persistence and selection of an expanded B cell clone in the setting of rituximab therapy for Sjogren's syndrome.

Hershberg U, Meng W, Zhang B, Haff N, St Clair EW, Cohen PL, McNair PD, Li L, Levesque MC, Luning Prak ET.

Arthritis Res Ther. 2014 Feb 11;16(1):R51. [Epub ahead of print]

PMID:
24517398
[PubMed - as supplied by publisher]
Free PMC Article
5.

European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma.

Engelhardt M, Terpos E, Kleber M, Gay F, Wäsch R, Morgan G, Cavo M, van de Donk N, Beilhack A, Bruno B, Johnsen HE, Hajek R, Driessen C, Ludwig H, Beksac M, Boccadoro M, Straka C, Brighen S, Gramatzki M, Larocca A, Lokhorst H, Magarotto V, Morabito F, Dimopoulos MA, Einsele H, Sonneveld P, Palumbo A; European Myeloma Network.

Haematologica. 2014 Feb;99(2):232-42. doi: 10.3324/haematol.2013.099358.

PMID:
24497560
[PubMed - in process]
Free PMC Article
6.

Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the National Health and Nutritional Examination Survey.

Landgren O, Graubard BI, Katzmann JA, Kyle RA, Ahmadizadeh I, Clark R, Kumar SK, Dispenzieri A, Greenberg AJ, Therneau TM, Melton LJ 3rd, Caporaso N, Korde N, Roschewski M, Costello R, McQuillan GM, Rajkumar SV.

Leukemia. 2014 Jul;28(7):1537-42. doi: 10.1038/leu.2014.34. Epub 2014 Jan 20.

PMID:
24441287
[PubMed - in process]
Free PMC Article
7.

A replicative self-renewal model for long-lived plasma cells: questioning irreversible cell cycle exit.

Tooze RM.

Front Immunol. 2013 Dec 18;4:460. doi: 10.3389/fimmu.2013.00460. Review.

PMID:
24385976
[PubMed]
Free PMC Article
8.

Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.

Fend F, Cabecadas J, Gaulard P, Jaffe ES, Kluin P, Kuzu I, Peterson L, Wotherspoon A, Sundström C.

J Hematop. 2012 Sep;5(3). doi: 10.1007/s12308-012-0148-6.

PMID:
24307917
[PubMed]
Free PMC Article
9.

Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden.

Turesson I, Kovalchik SA, Pfeiffer RM, Kristinsson SY, Goldin LR, Drayson MT, Landgren O.

Blood. 2014 Jan 16;123(3):338-45. doi: 10.1182/blood-2013-05-505487. Epub 2013 Nov 12.

PMID:
24222331
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Epigenetic modulating agents as a new therapeutic approach in multiple myeloma.

Maes K, Menu E, Van Valckenborgh E, Van Riet I, Vanderkerken K, De Bruyne E.

Cancers (Basel). 2013 Apr 15;5(2):430-61. doi: 10.3390/cancers5020430.

PMID:
24216985
[PubMed]
Free PMC Article
11.

C-src enriched serum microvesicles are generated in malignant plasma cell dyscrasia.

Di Noto G, Paolini L, Zendrini A, Radeghieri A, Caimi L, Ricotta D.

PLoS One. 2013 Aug 5;8(8):e70811. doi: 10.1371/journal.pone.0070811. Print 2013.

PMID:
23940647
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Cellular mechanisms of multiple myeloma bone disease.

Oranger A, Carbone C, Izzo M, Grano M.

Clin Dev Immunol. 2013;2013:289458. doi: 10.1155/2013/289458. Epub 2013 May 29. Review.

PMID:
23818912
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Genetic and molecular mechanisms in multiple myeloma: a route to better understand disease pathogenesis and heterogeneity.

Kyrtsonis MC, Bartzis V, Papanikolaou X, Koulieris E, Georgiou G, Dimou M, Tzenou T, Panayiotidis P.

Appl Clin Genet. 2010 Jul 28;3:41-51. Print 2010.

PMID:
23776351
[PubMed]
Free PMC Article
14.

Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma.

Rajkumar SV, Gupta V, Fonseca R, Dispenzieri A, Gonsalves WI, Larson D, Ketterling RP, Lust JA, Kyle RA, Kumar SK.

Leukemia. 2013 Aug;27(8):1738-44. doi: 10.1038/leu.2013.86. Epub 2013 Mar 21.

PMID:
23515097
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Molecular pathogenesis of multiple myeloma: basic and clinical updates.

Chesi M, Bergsagel PL.

Int J Hematol. 2013 Mar;97(3):313-23. doi: 10.1007/s12185-013-1291-2. Epub 2013 Feb 28. Review.

PMID:
23456262
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Sionov RV.

ISRN Hematol. 2013;2013:348212. doi: 10.1155/2013/348212. Epub 2013 Jan 29.

PMID:
23431463
[PubMed]
Free PMC Article
17.

Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach.

Baker A, Braggio E, Jacobus S, Jung S, Larson D, Therneau T, Dispenzieri A, Van Wier SA, Ahmann G, Levy J, Perkins L, Kim S, Henderson K, Vesole D, Rajkumar SV, Jelinek DF, Carpten J, Fonseca R.

Blood. 2013 Apr 18;121(16):3147-52. doi: 10.1182/blood-2012-07-443606. Epub 2013 Feb 19.

PMID:
23422747
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: a review of the current understanding of epidemiology, biology, risk stratification, and management of myeloma precursor disease.

Agarwal A, Ghobrial IM.

Clin Cancer Res. 2013 Mar 1;19(5):985-94. doi: 10.1158/1078-0432.CCR-12-2922. Epub 2012 Dec 5. Review.

PMID:
23224402
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Extramedullary involvement in multiple myeloma.

Bladé J, de Larrea CF, Rosiñol L.

Haematologica. 2012 Nov;97(11):1618-9. doi: 10.3324/haematol.2012.078519. No abstract available.

PMID:
23125242
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Bone marrow microenvironment in multiple myeloma progression.

Manier S, Sacco A, Leleu X, Ghobrial IM, Roccaro AM.

J Biomed Biotechnol. 2012;2012:157496. doi: 10.1155/2012/157496. Epub 2012 Oct 3. Review.

PMID:
23093834
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk